Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04716075
What this trial is testing

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more
Polish Lymphoma Research Group 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT01366092
What this trial is testing

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 35
Large-scale testing (Phase 3)Ended earlyNCT00003056
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaGraft Versus Host Disease
Baxalta now part of Shire 105
Large-scale testing (Phase 3)Not Yet RecruitingNCT07771439
What this trial is testing

Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Sanofi 356
Early research (Phase 1)Study completedNCT01911039
What this trial is testing

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Who this might be right for
Graft Versus Host DiseaseAllogeneic Hematopoietic Cell Transplant Recipient
Laura Johnston 14
Testing effectiveness (Phase 2)Looking for participantsNCT06663722
What this trial is testing

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseasecGVHD
University of Miami 49
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT02040623
What this trial is testing

Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)

Who this might be right for
Chronic Graft-versus-host Disease
Rigel Pharmaceuticals 35
Testing effectiveness (Phase 2)Ended earlyNCT02123966
What this trial is testing

An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft-versus-Host-DiseaseOral Mucosal Disease Due to Graft-versus-host Disease
Dana-Farber Cancer Institute 10
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12
Not applicableLooking for participantsNCT06656299
What this trial is testing

EOIB for Laparoscopic Cholecystectomy

Who this might be right for
CholecystitisCholecystitis, AcuteCholecystitis, Chronic+1 more
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00397332
What this trial is testing

Alefacept for Chronic Graft Versus Host Disease

Who this might be right for
Resistant Chronic GVHD
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Ended earlyNCT02461134
What this trial is testing

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Actelion 1
Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Testing effectiveness (Phase 2)Looking for participantsNCT05996627
What this trial is testing

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 82
Large-scale testing (Phase 3)Ended earlyNCT03584516
What this trial is testing

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Incyte Corporation 155
Not applicableStudy completedNCT00506233
What this trial is testing

Feasibility Study of Collecting Multicenter Chronic GVHD Data

Who this might be right for
Graft-Versus-Host Disease
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT03422627
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease cGVHD
Amgen 32
Not applicableStudy completedNCT04882605
What this trial is testing

KIR Sequencing and Typing for Allograft in Nancy

Who this might be right for
Stem Cell Transplant Complications
Central Hospital, Nancy, France 156
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Next Page